Gary Tong
Impact in
- Biological Psychiatry top 5%
-
- Neuroscience and Neuropharmacology Research
- Genetic Neurodegenerative Diseases
Papers in
- Physiology 12
- Alzheimer's disease research and treatments 9
-
- Receptor Mechanisms and Signaling 3
- Co-authors
- Jeffrey L. Cummings (2 shared papers)Clive Ballard (1 shared paper)Stuart A. Lipton (7 shared papers)Dongxian Zhang (6 shared papers)Maria Talantova (4 shared papers)Peng Xia (3 shared papers)Nobuki Nakanishi (5 shared papers)Yeonsook Shin (4 shared papers)
- Journals
- Alzheimer s & Dementia (7 papers)Journal of Alzheimer s Disease (2 papers)Journal of Neuroscience (2 papers)Neuron (2 papers)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Gary Tong
32 papers receiving 2.1k citations
Gary Tong's Hit Papers
Peers
Comparison fields: 5 of 119
- Biological Psychiatry 85
- Cellular and Molecular Neuroscience 638
- Neurology 259
- Physiology 718
- Psychiatry and Mental health 289
Countries citing papers authored by Gary Tong
This map shows the geographic impact of Gary Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Tong more than expected).
Fields of papers citing papers by Gary Tong
This network shows the impact of papers produced by Gary Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Tong. The network helps show where Gary Tong may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options Hit paper breakdown → | 2019 | 436 |
| 2 | Current state of Alzheimer’s fluid biomarkers Hit paper breakdown → | 2018 | 379 |
| 3 | 2009 | 339 | |
| 4 | 2009 | 97 | |
| 5 | 2009 | 95 | |
| 6 | 2007 | 91 | |
| 7 | 2019 | 87 | |
| 8 | 2010 | 72 | |
| 9 | 2012 | 72 | |
| 10 | 2007 | 72 | |
| 11 | 2008 | 59 | |
| 12 | 2012 | 55 | |
| 13 | 2015 | 51 | |
| 14 | 2012 | 36 | |
| 15 | 2006 | 34 | |
| 16 | 2004 | 31 | |
| 17 | 2007 | 29 | |
| 18 | 2012 | 26 | |
| 19 | 2007 | 19 | |
| 20 | 2013 | 18 |
About Gary Tong
Gary Tong is a scholar working on Physiology, Molecular Biology, Cellular and Molecular Neuroscience, Pharmacology and Developmental Neuroscience, having authored 35 papers that have together received 2.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Neurogenesis and neuroplasticity mechanisms (3 papers), Receptor Mechanisms and Signaling (3 papers), Gastrointestinal motility and disorders (2 papers), Migraine and Headache Studies (2 papers) and Biosensors and Analytical Detection (2 papers). The work is most often cited by research in Biological Psychiatry (85 citations), Cellular and Molecular Neuroscience (638 citations), Neurology (259 citations), Physiology (718 citations) and Psychiatry and Mental health (289 citations). Gary Tong has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Jeffrey L. Cummings, Clive Ballard, Stuart A. Lipton, Dongxian Zhang, Maria Talantova, Peng Xia, Nobuki Nakanishi, Yeonsook Shin, Shichun Tu and Michael R. Hayden. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, Journal of Neuroscience, Neuron and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.